The tweet was deleted by the author.
But we saved everything 🙂.
Nuvalent marked National Cancer Survivors Day by acknowledging the strength and resilience of cancer survivors. The company focused on those living with ALK+ and ROS1+ lung cancer.
Nuvalent expressed solidarity with patients, caregivers, and loved ones. The stock used hashtags to emphasize support for the ALK positive and ROS1 positive communities.
NUVL is currently trading at $90.95, which is well below the MA-20 at $101.12, MA-50 at $102.45, and MA-200 at $97.68, reinforcing a short-, medium-, and long-term bearish trend. The Ichimoku Kijun level on D1 is $100.21, which sits above the current price and acts as immediate resistance. Near-term support is found at the MA-200 level around $97.68, with further key support at the MA-100 near $102.35. Immediate resistance is at the Ichimoku Kijun ($100.21), followed by key resistance at the MA-50 ($102.45).
Momentum indicators on D1 point to strong bearish sentiment. MACD signals sell, and ADX at 13.28 suggests a weak but negative trend. RSI, CCI, and Stoch RSI all indicate oversold territory, highlighting stretched bearish momentum. BBP also remains deep in seller-dominated territory, confirming sellers are in control on the intraday. The AO supports the ongoing downward move. NUVL has fallen $19.44 (17.61%) from the previous weekly close of $110.39 and is currently at the very bottom of this week’s range near support. Weekly volatility stands at a high 24.3%, reflecting a sharp and sustained decline from the recent peak. In today’s session, NUVL is down 3.27%, aligning with the prevailing downside momentum.
For the coming week, the expected trading range is $89.00 to $94.00, keeping the price well above the 52-week low of $71.13 but under pressure from the highs near $113.02. The probability of a price increase is very low (less than 20%), with a substantial likelihood of further declines, based on the absence of bullish signals across all major weekly indicators except the longer-term MA-100 and MA-200. The baseline scenario points to sideways movement within this narrow range as oversold conditions could trigger some stabilization. A bullish scenario would require a decisive break above immediate resistance at $94.00, while a bearish scenario could see the price falling below $89.00 if the current weakness persists.
Previously it was reported that Nuvalent faced sustained downside pressure, with limited prospects for a near-term rebound amid weak technical signals. In the current environment, investors should watch for any shift in momentum or news catalysts that could alter the prevailing bearish scenario.